Production of RNA-based vaccines for safe, efficient and versatile alternative to conventional …

Keiji Itaka, Satoshi Uchida and colleagues at the Kawasaki Institute of Industrial Promotion, The University of Tokyo, Tokyo Medical and Dental University and Osaka Prefecture University, enhanced adjuvant properties of the RNA itself by utilizing the high immunogenicity of double stranded (ds)RNA.
Go to Source